Phosphoinositide 3-kinase δ inhibitor as a novel therapeutic agent in asthma

Seoung J. Park, Kyung-Hoon Min, Yong C. Lee

Research output: Contribution to journalReview article

20 Citations (Scopus)

Abstract

Multiple signal transduction pathways are involved in airway inflammation with one of the key signalling pathways being phosphoinositide 3-kinase (PI3K). Numerous components of the PI3K pathway play an important role in the expression and activation of inflammatory mediators, inflammatory cell recruitment, immune cell function, airway remodelling and corticosteroid insensitivity in asthma. More recently studies exploring the specific roles of different PI3K catalytic subunit isoforms in asthma have been initiated. Several of these have highlighted the importance of p110δ isoform as a novel target for therapeutic intervention in asthma. In this review the biological role of PI3Ks, especially PI3Kδ, are highlighted and the therapeutic potential of selective PI3Kδ inhibitor in asthma discussed.

Original languageEnglish
Pages (from-to)764-771
Number of pages8
JournalRespirology
Volume13
Issue number6
DOIs
Publication statusPublished - 2008 Sep 1
Externally publishedYes

Fingerprint

1-Phosphatidylinositol 4-Kinase
Asthma
Protein Isoforms
Airway Remodeling
Therapeutics
Phosphatidylinositol 3-Kinases
Signal Transduction
Catalytic Domain
Adrenal Cortex Hormones
Inflammation

Keywords

  • 1-phosphoinositide 3-kinase
  • Asthma
  • Inflammation
  • Lung

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Phosphoinositide 3-kinase δ inhibitor as a novel therapeutic agent in asthma. / Park, Seoung J.; Min, Kyung-Hoon; Lee, Yong C.

In: Respirology, Vol. 13, No. 6, 01.09.2008, p. 764-771.

Research output: Contribution to journalReview article

Park, Seoung J. ; Min, Kyung-Hoon ; Lee, Yong C. / Phosphoinositide 3-kinase δ inhibitor as a novel therapeutic agent in asthma. In: Respirology. 2008 ; Vol. 13, No. 6. pp. 764-771.
@article{487e5a2b3b9f461dae0fd258d89639d5,
title = "Phosphoinositide 3-kinase δ inhibitor as a novel therapeutic agent in asthma",
abstract = "Multiple signal transduction pathways are involved in airway inflammation with one of the key signalling pathways being phosphoinositide 3-kinase (PI3K). Numerous components of the PI3K pathway play an important role in the expression and activation of inflammatory mediators, inflammatory cell recruitment, immune cell function, airway remodelling and corticosteroid insensitivity in asthma. More recently studies exploring the specific roles of different PI3K catalytic subunit isoforms in asthma have been initiated. Several of these have highlighted the importance of p110δ isoform as a novel target for therapeutic intervention in asthma. In this review the biological role of PI3Ks, especially PI3Kδ, are highlighted and the therapeutic potential of selective PI3Kδ inhibitor in asthma discussed.",
keywords = "1-phosphoinositide 3-kinase, Asthma, Inflammation, Lung",
author = "Park, {Seoung J.} and Kyung-Hoon Min and Lee, {Yong C.}",
year = "2008",
month = "9",
day = "1",
doi = "10.1111/j.1440-1843.2008.01369.x",
language = "English",
volume = "13",
pages = "764--771",
journal = "Respirology",
issn = "1323-7799",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Phosphoinositide 3-kinase δ inhibitor as a novel therapeutic agent in asthma

AU - Park, Seoung J.

AU - Min, Kyung-Hoon

AU - Lee, Yong C.

PY - 2008/9/1

Y1 - 2008/9/1

N2 - Multiple signal transduction pathways are involved in airway inflammation with one of the key signalling pathways being phosphoinositide 3-kinase (PI3K). Numerous components of the PI3K pathway play an important role in the expression and activation of inflammatory mediators, inflammatory cell recruitment, immune cell function, airway remodelling and corticosteroid insensitivity in asthma. More recently studies exploring the specific roles of different PI3K catalytic subunit isoforms in asthma have been initiated. Several of these have highlighted the importance of p110δ isoform as a novel target for therapeutic intervention in asthma. In this review the biological role of PI3Ks, especially PI3Kδ, are highlighted and the therapeutic potential of selective PI3Kδ inhibitor in asthma discussed.

AB - Multiple signal transduction pathways are involved in airway inflammation with one of the key signalling pathways being phosphoinositide 3-kinase (PI3K). Numerous components of the PI3K pathway play an important role in the expression and activation of inflammatory mediators, inflammatory cell recruitment, immune cell function, airway remodelling and corticosteroid insensitivity in asthma. More recently studies exploring the specific roles of different PI3K catalytic subunit isoforms in asthma have been initiated. Several of these have highlighted the importance of p110δ isoform as a novel target for therapeutic intervention in asthma. In this review the biological role of PI3Ks, especially PI3Kδ, are highlighted and the therapeutic potential of selective PI3Kδ inhibitor in asthma discussed.

KW - 1-phosphoinositide 3-kinase

KW - Asthma

KW - Inflammation

KW - Lung

UR - http://www.scopus.com/inward/record.url?scp=51349091512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51349091512&partnerID=8YFLogxK

U2 - 10.1111/j.1440-1843.2008.01369.x

DO - 10.1111/j.1440-1843.2008.01369.x

M3 - Review article

C2 - 18811876

AN - SCOPUS:51349091512

VL - 13

SP - 764

EP - 771

JO - Respirology

JF - Respirology

SN - 1323-7799

IS - 6

ER -